entity

GLP-1

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about GLP-1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

26Connections
0Hypotheses
3Analyses
25Outgoing
1Incoming

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

Novel Therapy Index

idea · 10647 words

Device Therapies Comparison for CBS/PSP

therapeutic · 6867 words

Alpha-Synuclein Pathology

mechanism · 6288 words

Outgoing (25)

TargetRelationTypeStr
GLP-1Rbindsreceptor0.95
Insulin Signalingassociated_withpathway0.95
Insulin Signalingpromotespathway0.95
synaptic functionprotects_againstbiological_process0.80
cognitionimprovesbiological_process0.80

Incoming (1)

SourceRelationTypeStr
Tirzepatideactivatesdrug0.95

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (3)

Scientific analyses that reference this entity

How does engineered C. butyricum cross the blood-brain barrier to directly bind

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.675

What are the molecular mechanisms by which GLP-1RAs provide neuroprotective effe

neurodegeneration | 2026-04-14 | 0 hypotheses

Metabolic reprogramming in neurodegenerative disease

neurodegeneration | 2026-04-02 | 3 hypotheses Top: 0.398

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found